Online Activities
POC201
Mechanistic Insights and Emerging Treatment Options
Webcast
Unpacking the Evidence for Their Use Today and Tomorrow
Webcast
Looking Beyond Hemoglobin A1c
Webcast
A Case-Based Look at Exacerbation Prevention
Webcast
Debates and Discussions About Managing Moderate-to-Severe Disease
POC201
Updates on Treatment & Prevention Strategies for HIV and HCV
Webcast Series
Test Your Skills in Managing These Patients
Webcast
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
POC101
How the Pharmacist Can Make a Difference
Debates & Discussions on the Evolving Role of JAK Inhibitors
Optimizing the PCP’s Role in HIV Prevention
The Emerging Picture of Anemia in Chronic Kidney Disease
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Archived Activities
Digging Deep on Shared Decision-Making
Translating Guidelines Into Patient Care
A Guide to Healthcare Advances for Specialist Clinicians
Implications for PCSK9 Inhibitors in Clinical Practice
Interdisciplinary Management of Patients With Severe Asthma
Optimizing Management Strategies in Moderate-to-Severe Atopic Dermatitis
Mechanistic Insights and Evolving Treatment Options
Collaborative Care for Better Patient Outcomes
HIV as a Chronic Disease: A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
Debates and Discussions Around Cardiovascular and Renal Outcomes
Why It Matters in OB/GYN Practice Today
Improving Patient Outcomes Through Shared Clinical Decision Making
Debates and Discussions About Pustular Disease Subtypes
Let’s Talk Constipation
Realities, Challenges, and Opportunities to Improve Care
Course Description
Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, as should monitoring for catheter- or pump-related complications. This CME/CE-accredited Point of Care 201™ 2-part series discusses identification of candidates for IT therapy, available IT therapies, optimal treatment initiation and management, and both surgical implantation and pump refill techniques.
Realities, Challenges, and Opportunities to Improve Care
This activity is designed to update gastroenterologists, rheumatologists and other specialist clinicians on the latest evidence related to Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in disease pathophysiology and potential implications for future therapeutic strategies. The activity will provide foundational information, relevant across specialties.
Hot Topics in HBV, HCV, and NASH
HIV-Prevention Education for University Student Health Centers
